What does unrealized gains (losses) on hedge instruments mean?

This represents the change in the fair value of derivative instruments designated as cash flow hedges that are recognized in equity. It reflects the effectiveness of the company's strategy to mitigate risks associated with variable cash flows, such as interest rate or commodity price fluctuations. It is a key indicator of the company's risk management efficacy regarding future cash flow stability.

Bioventus BVS Unrealized gains (losses) on hedge instruments

Unrealized gains (losses) on hedge instruments at other companies

MedtronicMDT

——

Other financials

Income statement

See full

Revenue$132.1M+6.6%

Gross profit$90.8M+9.3%

Operating income$8.4M+72.8%

Net income$3.1M+218%

EPS (diluted)$0.04+200%

Balance sheet

See full

Cash & equivalents$35.8M+57.2%

Total debt$288.4M-21.2%

Total equity$188.9M+27.5%

Total assets$650.5M-5.9%

Cash flow

See full

Operating cash flow$8.9M+146%

CapEx$574.0K-30.5%

Free cash flow$8.4M+141%

Valuation

See full

Market cap$659.19M+51.7%

Enterprise value$911.76M+17.2%

P/E23.1×—

P/S1.1×+0.4×

Profitability

See full

Gross margin68.7%+1.2pp

Operating margin10%—

Net margin4.9%+3.2pp

FCF margin17.5%+13.2pp

Returns & leverage

See full

Return on equity16.9%+10.9pp

Debt / equity1.5×-0.9×

Current ratio1.7×+0.3×

Where this comes from

Reported directly by Bioventus in its filing.

Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax.

The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bioventus's unrealized gains (losses) on hedge instruments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bioventus's unrealized gains (losses) on hedge instruments?: Bioventus (BVS) reported unrealized gains (losses) on hedge instruments of $1M in Q1 2026.
What does unrealized gains (losses) on hedge instruments mean?: This represents the change in the fair value of derivative instruments designated as cash flow hedges that are recognized in equity. It reflects the effectiveness of the company's strategy to mitigate risks associated with variable cash flows, such as interest rate or commodity price fluctuations. It is a key indicator of the company's risk management efficacy regarding future cash flow stability.